Seres Therapeutics MCRB
NASDAQ MCRB
$2.40 +0.09 (+3.90%)
As of: Oct 21, 2026 · 9:56 AM EDT

Seres Therapeutics (MCRB) Non-Current Assets (2014 - 2026)

Updated

Seres Therapeutics (MCRB) reported Non-Current Assets of $59.24 million for Q2 2026, down 37.7% from $95.12 million a year earlier and down 30.9% from the prior quarter.

Analysis

Seres Therapeutics (MCRB) Non-Current Assets (2014 - 2026) Analysis & Trends

At the end of FY2025, Seres Therapeutics posted Non-Current Assets of $88.82 million, down 12.2% from FY2024.

  • Non-Current Assets has a five-year compound annual growth rate of 3.7% (FY2020 to FY2025).
  • By year, Non-Current Assets came in at $101.14 million in FY2024 (-44.8%), $183.19 million in FY2023 (+18.9%), $154.02 million in FY2022 (+200.6%) and $51.23 million in FY2021 (-30.9%).
  • The Q2 2026 figure ranks as the lowest quarterly Non-Current Assets since Q1 2022.
  • Year over year, Non-Current Assets has now declined in each of the last eight quarters, with an average decline of 30.1% over the last eight quarters.
  • The high point for year-over-year Non-Current Assets in five years was Q4 2022 (growth of 200.6%); the low point was Q2 2025 (a decline of 44.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $85.78 million (Q1 2026), $88.82 million (Q4 2025) and $91.95 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,129.39 Bn 1,097.98 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 615.68 Bn 534.21 Bn 17.26 Bn 141.29 Bn
3 AbbVie 505.77 Bn 478.89 Bn 12.70 Bn 101.45 Bn
4 Merck 366.50 Bn 320.88 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 297.33 Bn 261.32 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 261.02 Bn 234.71 Bn 12.86 Bn 87.87 Bn
7 Amgen 235.47 Bn 190.87 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 189.20 Bn 163.40 Bn 6.22 Bn 35.42 Bn
9 Pfizer 170.20 Bn 116.85 Bn 10.94 Bn 159.77 Bn
10 Seres Therapeutics 23.29 Mn -115.54 Mn - 59.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 59.24 Mn
Mar 31, 2026 85.78 Mn
Dec 31, 2025 88.82 Mn
Sep 30, 2025 91.95 Mn
Jun 30, 2025 95.12 Mn
Mar 31, 2025 98.10 Mn
Dec 31, 2024 101.14 Mn
Sep 30, 2024 105.81 Mn
Jun 30, 2024 172.47 Mn
Mar 31, 2024 176.08 Mn
Dec 31, 2023 183.19 Mn
Sep 30, 2023 153.31 Mn
Jun 30, 2023 155.15 Mn
Mar 31, 2023 154.11 Mn
Dec 31, 2022 154.02 Mn
Sep 30, 2022 64.36 Mn
Jun 30, 2022 63.62 Mn
Mar 31, 2022 56.64 Mn
Dec 31, 2021 51.23 Mn
Sep 30, 2021 37.48 Mn
API Access

Seres Therapeutics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=MCRB&period=max&api_key=YOUR_API_KEY